Search court records - Search Within: docket:(IPR2019-00207) AND court:("Patent Trial and Appeal Board"), page 13

All Courts
Federal Courts
Bankruptcies
PTAB
ITC

Filters

Display dockets
Display documents
- Decisions and Orders
- Exhibits
- Briefs and Motions
- Pleadings
- x Reset Selection

Like full text docket searches?

Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.

Click for

AnalyticsSearch

Motions and Pleadings

No motions found.

Displaying 174-188 of 224 results

sorted by

2036 Exhibit: Exhibit 2036 Thiboutot et al 2009

Document IPR2019-00207, No. 2036-67 Exhibit - Exhibit 2036 Thiboutot et al 2009 (P.T.A.B. Aug. 9, 2019)

... controlled study of appro priate size; d III Evidence from well designed trials without randomization, single group pre/post, cohort, time series, or matched case controlled studies; d IV Evidence from well designed nonexperimen ...

In addition, very few studies have compared light based treat ments with standard and well validated pharma ceutical treatments and none with the current recommended therapy for most types of acne combination therapy with a topical ...

Nonetheless, it seems that the use of lasers and light therapy alone or with photosensi tizers offer promise.

There are a variety of scars and treatment options that can be used to achieve signiﬁcant cosmetic improvement (Fig 19), but it must be noted that none of the currently available treatments achieve complete resolution of the scar.

Cite Document

Analyze

+ More Snippets

2008 Exhibit: Exhibit 2008 Ahluwalia Intl Publ No WO 2011014627

Document IPR2019-00207, No. 2008-39 Exhibit - Exhibit 2008 Ahluwalia Intl Publ No WO 2011014627 (P.T.A.B. Aug. 9, 2019)

... SEARCH RE PORT Information on patent family members International application No PCT/US20 1 0/04367 1 Publication Patent family date member(s) Patent document cited in search report Publication date I I I us 20071 22435 NONE ...

Cite Document

Analyze

2056 Exhibit: Exhibit 2056 Curriculum Vitae of Dr Leon Kircik 2019

Document IPR2019-00207, No. 2056-87 Exhibit - Exhibit 2056 Curriculum Vitae of Dr Leon Kircik 2019 (P.T.A.B. Aug. 9, 2019)

Summer AAD, Boston, MA July 2009 “Promiseb™ Topical Cream for the Treamtent of Mild to Moderate Seborrheic Dermatitis of the Face – A Pilot Study” Michale Jarratt M.D., James DelRosso M.D., Zoe Draelos M.D, Steven Kempers M.D., Leon Kircik M.D., Lawrence Parish M.D., Alan Mentor M.D., Boni Elewski M.D.

EADV, Istanbul Turkey, May 2008 “Moisturizer Use Enhances Facial Tolerability of Tazarotene 0.1% Cream Without Compromising Efficacy in Patients with Acne Vulgaris” Emil Tanghetti M.D., Zoe Draelos M.D., Pearl Grimes M.D., Sunil Dhawan M.D., Michael Gold M.D., Leon Kircik M.D., Lawrence Green M.D., Angela Moore M.D., Fran Cook-Bolden M.D.

32nd Annual Hawaii Dermatology Seminar, Waikoloa, HI, March 2008 Promiseb™ Topical Cream for the Treamtent of Mild to Moderate Seborrheic Dermatitis of the Face – A Pilot Study” Michale Jarratt M.D., James DelRosso M.D., Zoe Draelos M.D, Steven Kempers M.D., Leon Kircik M.D., Lawrence Parish M.D., Alan Mentor M.D., Boni Elewski M.D.

International Academy of Cosmetic Dermatology, Melbourne, Australia, December 2006 “Utilization of Narrow-Band UVB Light Therapy and Etanercept for the Treatment of Psoriasis (UNITE): Efficacy, Safety, and Patient-Reported Outcomes” Leon Kircik, Jerry Bagel, Neil Korman, Alan Menter, Craig A. Elmets, John Koo, Yu-Ching Yang, Chiun-Fang Chiou, Frank Dann, Seth R. Stevens EADV Rhodes, Greece, October 2006 “A Double-Blind, Randomized, Vehicle-Controlled Trial to Determine the Efficacy and Safety of Hydrocortisone Butyrate 0.1% Lipocream in the treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects William Abramovits, M.D., Elizabeth Alvarez-Connelly, M.D., Debra Breneman, M.D., Alicia Bucko, M.D., Zoe Draelos, M.D., Lawrence Eichenfield, M.D., Michael Jarratt, M.D., Candice Johnson, M.D., Steven Kempers, M.D., Leon Kircik, M.D., Robert Loss, M.D, Robert Matheson, M.D., Elaine Siegfried, M.D., Dow Stough, M.D., Hector Wiltz, M.D.

Sun City, South Africa Sept. 2014 “New Treatment in Psoriasis” DEF NPPA Meeting Las Vegas, NV July 2014 “Treatment of Erythema in Rosacea” Spring EADV Belgrade, Serbia May 2014 “Topical Ivermectin” Innovations in Acne and Rosacea Monte Carlo, Monaco May 2014 “Importance of Vehicles” Derm Update Toronto, Canada April 2014 “What’s New in Medicine Cabinet”

Cite Document

Analyze

2027 Exhibit: Exhibit 2027 Mills et al 1986

Document IPR2019-00207, No. 2027-58 Exhibit - Exhibit 2027 Mills et al 1986 (P.T.A.B. Aug. 9, 2019)

8 The intensity of fluorescence was graded on a O to 6 scale with O = none, 1 to 2 = mild fluorescence, 3 to 4 == moderate, and 5 to 6 = heavy fluorescence.

Cite Document

Analyze